Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Varex Imaging Corp Director's Dealing 2018

Sep 19, 2018

32856_dirs_2018-09-18_800336cb-f92f-4e1e-bb02-38e3bb167938.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Varex Imaging Corp (VREX)
CIK: 0001681622
Period of Report: 2018-09-14

Reporting Person: Jonaitis Mark S. (SVP and GM, X-Ray Sources)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-09-14 Common Stock M 11155 $19.21 Acquired 34789 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2018-09-14 Non-Qualified Stock Option (right to buy) $19.21 M 11155 Disposed 2018-11-11 Common Stock (11155.0) Direct

Footnotes

F1: Amount of securities beneficially owned at end of reporting period reflect 564 shares purchased on on April 27, 2018 under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Also includes 20 shares inadvertently omitted from a prior Form 4 filing.

F2: These options were granted in connection with Varex's spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested.